Table 3.
Variables | OS | PFS | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||||||
HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | |
MLR ≤0.30 vs. > 0.30 | / | / | 0.061 | / | / | 0.882 | / | / | 0.079 | / | / | 0.943 |
NLR ≤2.28 vs. > 2.28 | / | / | 0.121 | / | / | 0.854 | 2.767 | 1.320–5.800 | 0.007 | / | / | 0.103 |
CA125 ≤ 135.2 vs. > 135.2 | 3.828 | 1.468–9.983 | 0.006 | / | / | 0.074 | 2.665 | 1.306–5.436 | 0.007 | 2.057 | 0.989–4.282 | 0.054 |
ALB ≤39.6 vs. > 39.6 | 0.279 | 0.134–0.584 | 0.001 | 0.345 | 0.163–0.731 | 0.005 | 0.404 | 0.220–0.743 | 0.004 | 0.521 | 0.279–0.973 | 0.041 |
D2 ≤ 3.27 vs. > 3.27 | 5.118 | 2.273–11.520 | < 0.001 | 4.092 | 1.809–9.254 | 0.001 | 2.552 | 1.365–4.773 | 0.003 | 1.959 | 1.032–3.717 | 0.040 |
Abbreviations: PFS progression-free survival, OS overall survival, MLR monocyte to lymphocyte ratio, NLR neutrophil to lymphocyte ratio, ALB albumin, CA125 carbohydrate antigen 125, D2 D-dimer, HR hazard ratio, CI confidence interval
P values with statistical significance were denoted